Quadrant Biosciences has filed a notice of an exempt offering of securities to raise $25,425,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Quadrant Biosciences is raising $25,425,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Richard Uhlig played a key role…
